Viewing Study NCT02244502

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2026-02-24 @ 8:51 AM
Study NCT ID: NCT02244502
Status: UNKNOWN
Last Update Posted: 2016-09-21
First Post: 2014-09-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)
Sponsor: NovoCure Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ovarian Carcinoma View
None Treatment View
None Minimal toxicity View
None TTFields View
None Tumor Treating Fields View
None Novocure View
None Paclitaxel View
None Weekly paclitaxel View